Daniel Offen

Citée par

	Toutes	Depuis 2020
Citations	18401	5527
indice h	73	32
indice i10	189	116

1200

600

300

900

1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202595 129 161 207 274 285 346 390 475 435 532 528 603 678 765 745 882 852 756 846 778 886 876 993 1185 1054 1087 1057 148

Accès public

Tout afficher

8 articles

0 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Ran BarzilayUniversity of Pennsylvania and Children's Hospital of PhiladelphiaAdresse e-mail validée de email.chop.edu
Nisim PeretsPhd in Neurscience, Tel Aviv UniversityAdresse e-mail validée de mail.tau.ac.il
Abraham WeizmanProfessor of Psychiatry, Tel Aviv University, Tel Aviv, IsraelAdresse e-mail validée de post.tau.ac.il
Yoram CohenSchool of Chemistry and the Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, IsraelAdresse e-mail validée de tauex.tau.ac.il
Javier GanzHarvard Medical School / Boston Children's HospitalAdresse e-mail validée de childrens.harvard.edu
Noam ShemeshChampalimaud Research, Champalimaud FoundationAdresse e-mail validée de neuro.fchampalimaud.org
Daphne AtlasProfessor of NeurochemistryAdresse e-mail validée de mail.huji.ac.il
Rachela PopovtzerBar-Ilan UniversityAdresse e-mail validée de biu.ac.il
Oshra BetzerBar Ilan UniversityAdresse e-mail validée de biu.ac.il
Ariel AngelPhd in Neurscience, Tel Aviv UniversityAdresse e-mail validée de post.tau.ac.il
Edith HochhauserProfessor of medical research cardiologyAdresse e-mail validée de post.tau.ac.il
Felix Benninger, MDDepartment of Neurology, Rabin Medical Center, Petach Tikva, IsraelAdresse e-mail validée de clalit.org.il
Rotem VolkmanPhD student, Tel Aviv UniversityAdresse e-mail validée de mail.tau.ac.il
Shulamit LevenbergBiomedical Engineering, Technion, Israel Institute of TechnologyAdresse e-mail validée de bm.technion.ac.il
Hadar Segal-GavishTel Aviv UniversityAdresse e-mail validée de sheba.health.gov.il
Tamir Ben-Hurversity Medical CenterProfessor of Neurology and Chairman, Neurology, Hadassah - Hebrew UniAdresse e-mail validée de hadassah.org.il
Benkler ChenHarvard universityAdresse e-mail validée de fas.harvard.edu
Dimitrios KarussisProfessor of Neurology, Hebrew University, Jerusalem, IsraelAdresse e-mail validée de hadassah.org.il
Adi Vaknin-DembinskyNeurology Department, Multiple Sclerosis & Immunobiology Research, Hadassah Medical CenterAdresse e-mail validée de hadassah.org.il
micaela glatPostdoctoral fellow, Vienna Medical UniversityAdresse e-mail validée de meduniwien.ac.at

Suivre

Daniel Offen

Tel Aviv University

Adresse e-mail validée de post.tau.ac.il - Page d'accueil

Neuroscience


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier Y Gilgun-Sherki, E Melamed, D Offen Neuropharmacology 40 (8), 959-975, 2001	1146	2001
The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy Y Gilgun-Sherki, E Melamed, D Offen Journal of neurology 251, 261-268, 2004	846	2004
Antioxidant therapy in acute central nervous system injury: current state Y Gilgun-Sherki, Z Rosenbaum, E Melamed, D Offen Pharmacological reviews 54 (2), 271-284, 2002	787	2002
Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease M Vila, V Jackson-Lewis, S Vukosavic, R Djaldetti, G Liberatore, D Offen, ... Proceedings of the National Academy of Sciences 98 (5), 2837-2842, 2001	455	2001
The “dying-back” phenomenon of motor neurons in ALS M Dadon-Nachum, E Melamed, D Offen Journal of molecular neuroscience 43, 470-477, 2011	439	2011
In Vivo Neuroimaging of Exosomes Using Gold Nanoparticles O Betzer, N Perets, A Angel, M Motiei, T Sadan, G Yadid, D Offen, ... ACS nano 11 (11), 10883-10893, 2017	395	2017
Intranasal delivery of mesenchymal stem cell derived exosomes loaded with phosphatase and tensin homolog siRNA repairs complete spinal cord injury S Guo, N Perets, O Betzer, S Ben-Shaul, A Sheinin, I Michaelevski, ... ACS nano 13 (9), 10015-10028, 2019	370	2019
Golden exosomes selectively target brain pathologies in neurodegenerative and neurodevelopmental disorders N Perets, O Betzer, R Shapira, S Brenstein, A Angel, T Sadan, U Ashery, ... Nano letters 19 (6), 3422-3431, 2019	354	2019
Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1/2 and 2a … P Petrou, Y Gothelf, Z Argov, M Gotkine, YS Levy, I Kassis, ... JAMA neurology 73 (3), 337-344, 2016	344	2016
Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice E Hochhauser, S Kivity, D Offen, N Maulik, H Otani, Y Barhum, H Pannet, ... American Journal of Physiology-Heart and Circulatory Physiology 284 (6 …, 2003	339	2003
Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease D Offen, I Ziv, H Sternin, E Melamed, A Hochman Experimental neurology 141 (1), 32-39, 1996	323	1996
Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons—a possible novel pathogenetic mechanism in Parkinson's disease I Ziv, E Melamed, N Nardi, D Luria, A Achiron, D Offen, A Barzilai Neuroscience letters 170 (1), 136-140, 1994	311	1994
Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine neurotoxicity D Offen, PM Beart, NS Cheung, CJ Pascoe, A Hochman, S Gorodin, ... Proceedings of the National Academy of Sciences 95 (10), 5789-5794, 1998	287	1998
Apoptosis and Parkinson's disease N Lev, E Melamed, D Offen Progress in Neuro-Psychopharmacology and Biological Psychiatry 27 (2), 245-250, 2003	268	2003
Concise review: mesenchymal stem cells in neurodegenerative diseases R Volkman, D Offen Stem cells 35 (8), 1867-1880, 2017	229	2017
Human mesenchymal stem cells express neural genes, suggesting a neural predisposition NR Blondheim, YS Levy, T Ben-Zur, A Burshtein, T Cherlow, I Kan, ... Stem cells and development 15 (2), 141-164, 2006	225	2006
Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents MA Hellmann, H Panet, Y Barhum, E Melamed, D Offen Neuroscience letters 395 (2), 124-128, 2006	189	2006
Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease D Offen, Y Sherki, E Melamed, M Fridkin, DE Brenneman, I Gozes Brain research 854 (1-2), 257-262, 2000	186	2000
Protective effects of neurotrophic factor–secreting cells in a 6-OHDA rat model of Parkinson disease O Sadan, M Bahat-Stromza, Y Barhum, YS Levy, A Pisnevsky, H Peretz, ... Stem cells and development 18 (8), 1179-1190, 2009	178	2009
Enhanced Oxidative Stress and Altered Antioxidants in Brains of Bcl‐2‐Deficient Mice A Hochman, H Sternin, S Gorodin, S Korsmeyer, I Ziv, E Melamed, ... Journal of neurochemistry 71 (2), 741-748, 1998	176	1998

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs